This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jun;11(6):311.

doi: 10.1038/nrcardio.2014.53. Epub 2014 Apr 15.

Acute coronary syndromes: Aleglitazar trial findings reported

Bryony M Mearns

PMID: 24736759
DOI: 10.1038/nrcardio.2014.53

Comment

Acute coronary syndromes: Aleglitazar trial findings reported

Bryony M Mearns. Nat Rev Cardiol. 2014 Jun.

. 2014 Jun;11(6):311.

doi: 10.1038/nrcardio.2014.53. Epub 2014 Apr 15.

Author

Bryony M Mearns

PMID: 24736759
DOI: 10.1038/nrcardio.2014.53

No abstract available

PubMed Disclaimer

Comment on

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators. Lincoff AM, et al. JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321. JAMA. 2014. PMID: 24682069 Clinical Trial.

References

1. JAMA. 2014 Apr 16;311(15):1515-25 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information